Gagnon Robert E.
Opus Genetics, Inc. ยท Chief Financial Officer
Gagnon Robert E. is listed in public filings as officer: Chief Financial Officer. This Gagnon Robert E. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Opus Genetics, Inc. (IRD), Verastem, Inc. (VSTM), Harvard Bioscience, Inc. (HBIO), Bone Biologics Corporation (BBLGW), and Bone Biologics Corporation (BBLG). Investors use Gagnon Robert E.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $3.1M592.2k shares | SellApr 23, 2026 | $40.7K7.8k shares | $5.18 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --600k shares | Grant / ExerciseJan 22, 2026 | Disclosure amount unavailable400k shares | -- | -- | |
| $381k41.7k shares | SellDec 16, 2025 | $2.6K283 shares | $9.14 | -- | |
| $419k42k shares | SellSep 16, 2025 | $2.8K281 shares | $9.99 | -- | |
| --200k shares | Grant / ExerciseSep 10, 2025 | Disclosure amount unavailable200k shares | -- | -- | |
| $308k250k shares | Grant / ExerciseSep 2, 2025 | $307.5K250k shares | $1.23 | -- | |
| --110k shares | Grant / ExerciseJul 16, 2025 | Disclosure amount unavailable110k shares | -- | -- | |
| $239k42.2k shares | SellJun 16, 2025 | $1.6K284 shares | $5.65 | -- | |
| $55k62.9k shares | Grant / ExerciseJun 4, 2025 | $55.3K62.9k shares | $0.88 | -- | |
| $55k62.9k shares | Grant / ExerciseJun 4, 2025 | $55.3K62.9k shares | $0.88 | -- | |
| --42.5k shares | Grant / ExerciseMay 22, 2025 | Disclosure amount unavailable8.3k shares | -- | -- | |
| $94k12.5k shares | Grant / ExerciseMay 22, 2025 | $93.5K12.5k shares | $7.48 | -- | |
| $238k34.2k shares | SellMar 17, 2025 | $2.0K284 shares | $6.95 | -- | |
| $151k34.5k shares | SellDec 19, 2024 | $568130 shares | $4.37 | -- | |
| $157k34.6k shares | SellDec 16, 2024 | $1.3K285 shares | $4.54 | -- | |
| $97k34.9k shares | SellSep 19, 2024 | $365131 shares | $2.79 | -- | |
| $53k30.7k shares | Grant / ExerciseSep 17, 2024 | $53.1K30.7k shares | $1.73 | -- | |
| $53k30.7k shares | Grant / ExerciseSep 17, 2024 | $53.1K30.7k shares | $1.73 | -- | |
| $98k35k shares | SellSep 16, 2024 | $804287 shares | $2.80 | -- | |
| $113k35.3k shares | SellJun 20, 2024 | $421131 shares | $3.21 | -- | |
| --35.4k shares | Grant / ExerciseJun 18, 2024 | Disclosure amount unavailable8.3k shares | -- | -- | |
| $41k12.5k shares | Grant / ExerciseJun 18, 2024 | $40.9K12.5k shares | $3.27 | -- | |
| $95k27.1k shares | SellJun 17, 2024 | $988283 shares | $3.49 | -- |